Despite a dip in the fortunes of the biotechnology industry,
bioinformatics firm BlueGnome has achieved profit in less than
three years since its formation. The firm's fortunes are in
contrast to similar start up firms within...
A clear legal basis has been established for the first time which
will enable research institutions to use molecular biology
techniques for which provate companies have dominant patent
positions without signing away the rights to...